{"id":"https://openalex.org/W78071506","doi":"https://doi.org/10.1182/blood.v92.6.1918","title":"Long-Term Follow-Up of Patients With Hairy Cell Leukemia After Cladribine Treatment","display_name":"Long-Term Follow-Up of Patients With Hairy Cell Leukemia After Cladribine Treatment","publication_year":1998,"publication_date":"1998-09-15","ids":{"openalex":"https://openalex.org/W78071506","doi":"https://doi.org/10.1182/blood.v92.6.1918","mag":"78071506","pmid":"https://pubmed.ncbi.nlm.nih.gov/9731048"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v92.6.1918","doi":"https://doi.org/10.1182/blood.v92.6.1918","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v92.6.1918","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W78071506"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075536647","display_name":"Alan Saven","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123431417","display_name":"Scripps Research Institute","ror":"https://ror.org/02dxx6824","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I123431417"]},{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210146328","display_name":"Scripps Clinic","ror":"https://ror.org/05kwjwj05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1311914864","https://openalex.org/I4210146328"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Saven","raw_affiliation_strings":["From the Division of Hematology/Oncology, Ida M. and Cecil H. Green Cancer Center, Scripps Clinic, La Jolla, CA; The Scripps Research Institute, La Jolla, CA; and the Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA","Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA","The Scripps Research Institute, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Hematology/Oncology, Ida M. and Cecil H. Green Cancer Center, Scripps Clinic, La Jolla, CA; The Scripps Research Institute, La Jolla, CA; and the Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I123431417","https://openalex.org/I1282927834","https://openalex.org/I4210146328"]},{"raw_affiliation_string":"Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I1282927834","https://openalex.org/I161318765"]},{"raw_affiliation_string":"The Scripps Research Institute, La Jolla, CA","institution_ids":["https://openalex.org/I123431417"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069344923","display_name":"Carol Burian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123431417","display_name":"Scripps Research Institute","ror":"https://ror.org/02dxx6824","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I123431417"]},{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210146328","display_name":"Scripps Clinic","ror":"https://ror.org/05kwjwj05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1311914864","https://openalex.org/I4210146328"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carol Burian","raw_affiliation_strings":["From the Division of Hematology/Oncology, Ida M. and Cecil H. Green Cancer Center, Scripps Clinic, La Jolla, CA; The Scripps Research Institute, La Jolla, CA; and the Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA","Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA","The Scripps Research Institute, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Hematology/Oncology, Ida M. and Cecil H. Green Cancer Center, Scripps Clinic, La Jolla, CA; The Scripps Research Institute, La Jolla, CA; and the Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I123431417","https://openalex.org/I1282927834","https://openalex.org/I4210146328"]},{"raw_affiliation_string":"Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I1282927834","https://openalex.org/I161318765"]},{"raw_affiliation_string":"The Scripps Research Institute, La Jolla, CA","institution_ids":["https://openalex.org/I123431417"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090028133","display_name":"James A. Koziol","orcid":"https://orcid.org/0000-0002-0009-7987","observed_orcids":["https://orcid.org/0000-0002-0009-7987","https://orcid.org/0009-0000-6793-3583"]},"institutions":[{"id":"https://openalex.org/I123431417","display_name":"Scripps Research Institute","ror":"https://ror.org/02dxx6824","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I123431417"]},{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210146328","display_name":"Scripps Clinic","ror":"https://ror.org/05kwjwj05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1311914864","https://openalex.org/I4210146328"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James A. Koziol","raw_affiliation_strings":["From the Division of Hematology/Oncology, Ida M. and Cecil H. Green Cancer Center, Scripps Clinic, La Jolla, CA; The Scripps Research Institute, La Jolla, CA; and the Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA","Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA","The Scripps Research Institute, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Hematology/Oncology, Ida M. and Cecil H. Green Cancer Center, Scripps Clinic, La Jolla, CA; The Scripps Research Institute, La Jolla, CA; and the Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I123431417","https://openalex.org/I1282927834","https://openalex.org/I4210146328"]},{"raw_affiliation_string":"Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I1282927834","https://openalex.org/I161318765"]},{"raw_affiliation_string":"The Scripps Research Institute, La Jolla, CA","institution_ids":["https://openalex.org/I123431417"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034476546","display_name":"Lawrence D. Piro","orcid":"https://orcid.org/0009-0004-2809-2012","observed_orcids":["https://orcid.org/0009-0004-2809-2012"]},"institutions":[{"id":"https://openalex.org/I123431417","display_name":"Scripps Research Institute","ror":"https://ror.org/02dxx6824","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I123431417"]},{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]},{"id":"https://openalex.org/I4210146328","display_name":"Scripps Clinic","ror":"https://ror.org/05kwjwj05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1311914864","https://openalex.org/I4210146328"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence D. Piro","raw_affiliation_strings":["From the Division of Hematology/Oncology, Ida M. and Cecil H. Green Cancer Center, Scripps Clinic, La Jolla, CA; The Scripps Research Institute, La Jolla, CA; and the Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA","The Scripps Research Institute, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Hematology/Oncology, Ida M. and Cecil H. Green Cancer Center, Scripps Clinic, La Jolla, CA; The Scripps Research Institute, La Jolla, CA; and the Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I123431417","https://openalex.org/I1282927834","https://openalex.org/I4210146328"]},{"raw_affiliation_string":"The Scripps Research Institute, La Jolla, CA","institution_ids":["https://openalex.org/I123431417"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":7.8634,"has_fulltext":false,"cited_by_count":332,"citation_normalized_percentile":{"value":0.98043493,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"92","issue":"6","first_page":"1918","last_page":"1926"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.006300000008195639,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12159","display_name":"T-cell and Retrovirus Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hairy-cell-leukemia","display_name":"hairy cell leukemia","score":1.0},{"id":"https://openalex.org/keywords/cladribine","display_name":"cladribine","score":0.996999979019165},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.7360000014305115},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.843999981880188},{"id":"https://openalex.org/keywords/retreatment","display_name":"retreatment","score":0.8550000190734863},{"id":"https://openalex.org/keywords/second-neoplasms","display_name":"second neoplasms","score":0.9110000133514404},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.49799999594688416},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.7730000019073486},{"id":"https://openalex.org/keywords/long-term-outcomes","display_name":"long-term outcomes","score":0.5339999794960022},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.6669999957084656}],"concepts":[{"id":"https://openalex.org/C2779200787","wikidata":"https://www.wikidata.org/wiki/Q414030","display_name":"Cladribine","level":2,"score":0.9671292304992676},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.822767972946167},{"id":"https://openalex.org/C2780483514","wikidata":"https://www.wikidata.org/wiki/Q201299","display_name":"Hairy cell leukemia","level":3,"score":0.7112590074539185},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6289572715759277},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5888410806655884},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4909389317035675},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.43891647458076477},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.42264100909233093}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007372","descriptor_name":"Interferons","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007943","descriptor_name":"Leukemia, Hairy Cell","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D007943","descriptor_name":"Leukemia, Hairy Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007943","descriptor_name":"Leukemia, Hairy Cell","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D007943","descriptor_name":"Leukemia, Hairy Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013156","descriptor_name":"Splenectomy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015649","descriptor_name":"Pentostatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016609","descriptor_name":"Neoplasms, Second Primary","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017338","descriptor_name":"Cladribine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017338","descriptor_name":"Cladribine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1182/blood.v92.6.1918","doi":"https://doi.org/10.1182/blood.v92.6.1918","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v92.6.1918","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"doi:10.1182/blood.v92.6.1918.418k33_1918_1926","doi":"https://doi.org/10.1182/blood.v92.6.1918.418k33_1918_1926","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v92.6.1918.418k33_1918_1926","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:9731048","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9731048","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W85824607","https://openalex.org/W129142841","https://openalex.org/W137224267","https://openalex.org/W149140897","https://openalex.org/W159715420","https://openalex.org/W1570918622","https://openalex.org/W1580788756","https://openalex.org/W1605056933","https://openalex.org/W1882769651","https://openalex.org/W1899393576","https://openalex.org/W1909861673","https://openalex.org/W1910475489","https://openalex.org/W1928244181","https://openalex.org/W1979300931","https://openalex.org/W1988783929","https://openalex.org/W1995570857","https://openalex.org/W2041895922","https://openalex.org/W2076668534","https://openalex.org/W2086984633","https://openalex.org/W2161633568","https://openalex.org/W2244152503","https://openalex.org/W2305441371","https://openalex.org/W2314659489","https://openalex.org/W2328976528","https://openalex.org/W2410616529","https://openalex.org/W2414973427","https://openalex.org/W2417874335","https://openalex.org/W2442079786","https://openalex.org/W3041047318","https://openalex.org/W3147894994","https://openalex.org/W4249397316"],"related_works":["https://openalex.org/W2078641935","https://openalex.org/W2073515966","https://openalex.org/W654921306","https://openalex.org/W1928244181","https://openalex.org/W4285806034","https://openalex.org/W2906930967","https://openalex.org/W2578575283","https://openalex.org/W2589500086","https://openalex.org/W4318451969","https://openalex.org/W4416233253"],"abstract_inverted_index":{"Hairy":[0],"cell":[1,66,268],"leukemia":[2,67],"is":[3],"a":[4,26,121,141,255],"chronic":[5],"B-cell":[6],"disorder":[7],"that":[8],"follows":[9],"an":[10,114,125,200],"indolent,":[11],"but":[12],"progressive":[13],"course.":[14,28],"Cladribine":[15,250],"(2-chlorodeoxyadenosine)":[16],"induces":[17],"complete":[18,116,160,183,226,237],"remissions":[19],"in":[20,228],"the":[21,31,97,229],"majority":[22,231],"of":[23,50,61,91,129,132,143,175,203,222,232],"patients":[24,51,63,136,170,191,265],"after":[25],"single":[27],"We":[29],"report":[30],"long-term":[32,259],"outcomes,":[33],"including":[34],"response":[35,117,123,130],"rates":[36,49,235],"and":[37,47,103,118,162,185,254,258],"their":[38],"duration;":[39],"time-to-treatment":[40],"failure":[41],"(TTF)":[42],"rates;":[43],"retreatment":[44],"results;":[45],"toxicities;":[46],"survival":[48,213],"treated":[52,69,171],"at":[53,72,140,155,177,217],"Scripps":[54],"Clinic":[55],"(La":[56],"Jolla,":[57],"CA).":[58],"A":[59],"total":[60],"358":[62],"with":[64,70,124,172,199,248,266],"hairy":[65,267],"were":[68,239],"cladribine":[71,176,223],"0.087":[73],"or":[74],"0.1":[75],"mg/kg":[76],"body":[77],"weight":[78],"per":[79],"day":[80],"by":[81],"continuous":[82],"intravenous":[83],"infusion":[84],"for":[85,149,159,164,236],"7":[86],"days.":[87],"The":[88,146,211],"expected":[89],"number":[90],"second":[92,173,194],"neoplasms":[93,195],"was":[94,153,215],"based":[95],"on":[96],"National":[98],"Cancer":[99],"Institute's":[100],"Surveillance":[101],"Epidemiology":[102],"End":[104],"Results":[105],"data.":[106],"Of":[107,167],"349":[108],"evaluable":[109,169],"patients,":[110],"319":[111],"(91%)":[112],"achieved":[113,182],"initial":[115],"22":[119],"(7%)":[120],"partial":[122,165,188],"overall":[126,212],"median":[127,142],"duration":[128],"follow-up":[131],"52":[133],"months.":[134,145,219],"Ninety":[135],"(26%)":[137,187],"had":[138],"relapsed":[139],"29":[144],"TTF":[147],"rate":[148,214],"all":[150],"341":[151],"responders":[152,238],"19%":[154],"48":[156,218],"months,":[157],"16%":[158],"responders,":[161],"54%":[163],"responders.":[166],"53":[168],"courses":[174,221],"first":[178],"relapse,":[179],"33":[180],"(62%)":[181],"responses":[184,227],"14":[186],"responses.":[189],"Twenty-seven":[190],"(8%)":[192],"developed":[193],"(only":[196],"1":[197],"hematopoietic)":[198],"observed-to-expected":[201],"ratio":[202],"1.88":[204],"(95%":[205],"confidence":[206],"interval,":[207],"1.24":[208],"to":[209,264],"2.74).":[210],"96%":[216],"Single":[220],"induced":[224],"long-lasting":[225],"vast":[230],"patients.":[233],"Relapse":[234],"low.":[240],"Patients":[241],"who":[242],"relapse":[243],"can":[244],"be":[245],"successfully":[246],"retreated":[247],"cladribine.":[249],"has":[251],"high":[252],"efficacy":[253],"favorable":[256],"acute":[257],"toxicity":[260],"profile":[261],"when":[262],"administered":[263],"leukemia.":[269]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":17},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}